Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype.

作者: Beth A. McCullough , Marc Yudkoff , Mark L. Batshaw , James M. Wilson , Steven E. Raper

DOI: 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M

关键词: Ornithine transcarbamylaseOrnithine transcarbamylase deficiencyInborn error of metabolismPhenotypeInternal medicineBiologyGenotypeEndocrinologyUrea cycleMutationAge of onsetGenetics

摘要: Ornithine transcarbamylase (OTC) deficiency, a partially dominant X-linked disorder, is the most common inherited defect of urea cycle. Previous reports suggested variable phenotypic spectrum, and several studies documented different "private" mutations in OTC genes patients. Our laboratory identified disease-causing 157 families with 100 which came to medical attention through hemizygous propositus 57 index case was heterozygous female. We correlated genotype age onset, liver activity, incorporation nitrogen into urea, peak plasma ammonia levels. The "neonatal onset" group has homogeneous clinical biochemical phenotype, whereas "late shows an extremely wide phenotype; 60% are associated exclusively acute neonatal hyperammonemic coma. remaining caused nonuniform phenotype ranging from severe disease no symptoms; 31% gene occur CpG dinucleotides (methylation-mediated deamination), none them accounted for more than 4% total. Eighty-six percent represented single-base substitutions 68% were transitions. G-to-A C-to-T transitions frequent (34 21%, respectively) C-to-A, A-to-C, C-to-G, T-to-A transversions least (1.5-3%). Twenty propositi 77% propositae carried new mutations. Forty female germinal this number appears much smaller male These data allow classification patients deficiency at two groups who have discordant course prognoses. In addition, they improve our understanding on origin better counseling affected families.

参考文章(33)
B. François, L.E. Rosenberg, F. Kalousek, Isolation and characterization of ornithine transcarbamylase from normal human liver. Journal of Biological Chemistry. ,vol. 253, pp. 3939- 3944 ,(1978) , 10.1016/S0021-9258(17)34781-6
T. Uchino, F. Endo, I. Matsuda, Neurodevelopmental outcome of long-term therapy of urea cycle disorders in Japan. Journal of Inherited Metabolic Disease. ,vol. 21, pp. 151- 159 ,(1998) , 10.1023/A:1005374027693
D. J. Schaid, R. P. Ketterling, E. Vielhaber, C. D. K. Bottema, S. S. Sommer, C. L. Sexauer, M. P. Cohen, Germ-line origins of mutation in families with hemophilia B: the sex ratio varies with the type of mutation. American Journal of Human Genetics. ,vol. 52, pp. 152- 166 ,(1993)
M. Tuchman, H. Morizono, B. S. Rajagopal, R. J. Plante, N. M. Allewell, The biochemical and molecular spectrum of ornithine transcarbamylase deficiency Journal of Inherited Metabolic Disease. ,vol. 21, pp. 40- 58 ,(1998) , 10.1023/A:1005353407220
Mendel Tuchman, Robert A Holzknecht, Amelia B Gueron, Susan A Berry, Michael Y Tsai, Six new mutations in the ornithine transcarbamylase gene detected by single-strand conformational polymorphism. Pediatric Research. ,vol. 32, pp. 600- 604 ,(1992) , 10.1203/00006450-199211000-00024
Toshinobu Matsuura, Ryuuji Hoshide, Chiaki Setoyama, Satoru Komaki, Koji Kiwaki, Fumio Endo, Shigeyuki Nishikawa, Ichiro Matsuda, Expression of four mutant human ornithine transcarbamylase genes in cultured Cos 1 cells relates to clinical phenotypes Human Genetics. ,vol. 93, pp. 129- 134 ,(1994) , 10.1007/BF00210596
M Tuchman, H Morizono, O Reish, X Yuan, N M Allewell, The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations. Journal of Medical Genetics. ,vol. 32, pp. 680- 688 ,(1995) , 10.1136/JMG.32.9.680
Atsushi Nishiyori, M. Yoshino, Hirohisa Kato, Toshinobu Matsuura, Ryuuji Hoshide, Ichiro Matsuda, Tateo Kuno, Sumio Miyazaki, Shin-ichi Hirose, Ryu-ichi Kuromaru, Masataka Mori, The R40h mutation in a late onset type of human ornithine transcarbamylase deficiency in male patients Human Genetics. ,vol. 99, pp. 171- 176 ,(1997) , 10.1007/S004390050333